Neurotomy of Optic Nerve in Non-Arthritic Anterior Ischemic Optic Neuropathy

This study has been completed.

Sponsor:

Information provided by:

Shaheed Beheshti Medical University

ClinicalTrials.gov Identifier:

NCT00372021

First received: September 5, 2006

Last updated: October 11, 2006

Last verified: November 2002

History of Changes

Tracking Information

First Received Date ^ICMJE

September 5, 2006

Last Updated Date

October 11, 2006

Start Date ^ICMJE

January 2003

Primary Completion Date

Not Provided

Current Primary Outcome Measures ^ICMJE

Not Provided

Original Primary Outcome Measures ^ICMJE

Not Provided

Change History

Complete list of historical versions of study NCT00372021 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

Not Provided

Original Secondary Outcome Measures ^ICMJE

Not Provided

Current Other Outcome Measures ^ICMJE

Not Provided

Original Other Outcome Measures ^ICMJE

Not Provided

Descriptive Information

Brief Title ^ICMJE

Neurotomy of Optic Nerve in Non-Arthritic Anterior Ischemic Optic Neuropathy

Official Title ^ICMJE

Not Provided

Brief Summary

Non-arthritic anterior ischemic optic neuropathy is the most common cause of sudden visual loss due to optic nerve involvement in patients above 50 years old. As this problem can be considered as a sclera out let syndrome an there is no effective and successful treatment for it, we decided to do a neurotomy procedure and relax the involved optic nerve in order to achieve acceptable treating outcome.

Detailed Description

Not Provided

Study Type ^ICMJE

Interventional

Study Phase

Phase 1
Phase 2

Study Design ^ICMJE

Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind
Primary Purpose: Treatment

Condition ^ICMJE

Non Arthritic Anterior Ischemic Optic Neuropathy

Intervention ^ICMJE

Procedure: optic nerve neurotomy

Study Arm (s)

Not Provided

Publications *

Not Provided

* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Completed

Enrollment ^ICMJE

Not Provided

Completion Date

Not Provided

Primary Completion Date

Not Provided

Eligibility Criteria ^ICMJE

Inclusion Criteria:

Patients with non-arthritic anterior ischemic optic nerve

Exclusion Criteria:

Visual acuity more than 20/200
Other intra occular operations
Passing more than 4 weeks of the problem
Arthritic anterior ischemic optic nerve
Age under 50 years
Consumption of previous pharmaceutical treatment

Gender

Both

Ages

50 Years and older

Accepts Healthy Volunteers

Contacts ^ICMJE

Contact information is only displayed when the study is recruiting subjects

Location Countries ^ICMJE

Iran, Islamic Republic of

Administrative Information

NCT Number ^ICMJE

NCT00372021

Other Study ID Numbers ^ICMJE

8136

Has Data Monitoring Committee

Not Provided

Responsible Party

Not Provided

Study Sponsor ^ICMJE

Shaheed Beheshti Medical University

Collaborators ^ICMJE

Not Provided

Investigators ^ICMJE

Principal Investigator:

Masoud Soheilian, MD

Ophthalmic Research Center of Shaheed Beheshti Medical University

Information Provided By

Shaheed Beheshti Medical University

Verification Date

November 2002

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top